AstraZeneca PLC

AZN: Imfinzi Combination Improves Disease-Free Survival In Phase III High-Risk Bladder Cancer Trial

09 5 2025 01:32:42 提供 NASDAQ US Markets

AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials

02 5 2025 01:50:57 提供 NASDAQ US Markets

AstraZeneca Q1 Results Climb, Maintains FY25 Outlook; Lifts Dividend

29 4 2025 01:55:29 提供 NASDAQ US Markets

AZN June 2027 Options Begin Trading

24 4 2025 10:32:42 提供 NASDAQ US Markets

AZN June 2027 Options Begin Trading

24 4 2025 10:29:50 提供 NASDAQ Stocks

NetDania - New 12 months Low: ASTRAZENECA PLC

09 4 2025 02:15:01 提供 NetDania Notify

Relative Strength Alert For AstraZeneca

07 4 2025 13:17:02 提供 NASDAQ US Markets

Relative Strength Alert For AstraZeneca

07 4 2025 13:09:15 提供 NASDAQ Stocks

NetDania - New 12 months Low: ASTRAZENECA PLC

07 4 2025 02:15:02 提供 NetDania Notify

AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment

04 4 2025 01:42:00 提供 NASDAQ US Markets

AZN Makes Bullish Cross Above Critical Moving Average

03 4 2025 14:19:41 提供 NASDAQ US Markets

Nasdaq 100 Movers: LULU, AZN

03 4 2025 09:46:36 提供 NASDAQ US Markets

Nasdaq 100 Movers: LULU, AZN

03 4 2025 09:27:06 提供 NASDAQ Stocks

AstraZeneca's Imfinzi Combo Approved In US For Muscle-Invasive Bladder Cancer Treatment

31 3 2025 01:48:35 提供 NASDAQ US Markets

AZN : Study Confirms TAGRISSO As Essential Therapy For EGFR-Mutated Lung Cancer Across All Stages

25 3 2025 20:46:31 提供 NASDAQ US Markets

Nasdaq 100 Movers: AZN, TSLA

24 3 2025 11:22:08 提供 NASDAQ US Markets

AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal

17 3 2025 02:30:11 提供 NASDAQ US Markets

AZN May 2nd Options Begin Trading

13 3 2025 10:37:56 提供 NASDAQ US Markets

AZN Makes Notable Cross Below Critical Moving Average

11 3 2025 10:58:07 提供 NASDAQ US Markets

AZN : Imfinzi Improves Event-Free Survival In Early-Stage Gastric & GEJ Cancers In Phase III Trial

07 3 2025 01:51:13 提供 NASDAQ US Markets